[go: up one dir, main page]

HK1048498A1 - 自然殺傷細胞的增殖方法 - Google Patents

自然殺傷細胞的增殖方法

Info

Publication number
HK1048498A1
HK1048498A1 HK03100622.3A HK03100622A HK1048498A1 HK 1048498 A1 HK1048498 A1 HK 1048498A1 HK 03100622 A HK03100622 A HK 03100622A HK 1048498 A1 HK1048498 A1 HK 1048498A1
Authority
HK
Hong Kong
Prior art keywords
natural killer
cell proliferation
killer cell
human
proliferation method
Prior art date
Application number
HK03100622.3A
Other languages
English (en)
Inventor
Ohno Tadao
Saijoh Kaoru
Original Assignee
理化學研究所
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 理化學研究所 filed Critical 理化學研究所
Publication of HK1048498A1 publication Critical patent/HK1048498A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00Cellular immunotherapy
    • A61K40/10Cellular immunotherapy characterised by the cell type used
    • A61K40/15Natural-killer [NK] cells; Natural-killer T [NKT] cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00Cellular immunotherapy
    • A61K40/40Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41Vertebrate antigens
    • A61K40/42Cancer antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0636T lymphocytes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0646Natural killers cells [NK], NKT cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20Cytokines; Chemokines
    • C12N2501/23Interleukins [IL]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK03100622.3A 1999-11-26 2003-01-23 自然殺傷細胞的增殖方法 HK1048498A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP33607999A JP3619853B2 (ja) 1999-11-26 1999-11-26 ナチュラルキラー細胞の増殖方法
PCT/JP2000/008079 WO2001038494A1 (en) 1999-11-26 2000-11-16 Method of proliferating natural killer cells

Publications (1)

Publication Number Publication Date
HK1048498A1 true HK1048498A1 (zh) 2003-04-04

Family

ID=18295489

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03100622.3A HK1048498A1 (zh) 1999-11-26 2003-01-23 自然殺傷細胞的增殖方法

Country Status (10)

Country Link
EP (1) EP1233058B1 (zh)
JP (1) JP3619853B2 (zh)
KR (1) KR20030032905A (zh)
CN (1) CN1237170C (zh)
AT (1) ATE348876T1 (zh)
CA (1) CA2393322A1 (zh)
DE (1) DE60032508D1 (zh)
HK (1) HK1048498A1 (zh)
TW (1) TWI224137B (zh)
WO (1) WO2001038494A1 (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030032961A (ko) * 2000-06-06 2003-04-26 기린 비루 가부시키가이샤 내츄럴 킬러 t 세포의 증폭 방법
JP2002045174A (ja) * 2000-07-31 2002-02-12 Inst Of Physical & Chemical Res ナチュラルキラー細胞増殖法
CA2544155C (en) 2004-09-15 2012-10-16 Tetsuya Kuhara Drug and method for proliferating natural killer cells
KR101148901B1 (ko) 2004-09-29 2012-05-29 모리나가 뉴교 가부시키가이샤 고혈당 개선용 음식품
JP2008109866A (ja) * 2006-10-30 2008-05-15 Jms Co Ltd 培地添加剤、この培地添加剤を含む培地、及びこの培地を用いた細胞の培養方法
MX2007015736A (es) * 2007-12-11 2009-06-11 Val De Bio S De R L De C V Procedimiento para sensibilizar celulas y el uso de las mismas para tratamiento de tumores.
US9511092B2 (en) 2013-01-28 2016-12-06 St. Jude Children's Research Hospital, Inc. Chimeric receptor with NKG2D specificity for use in cell therapy against cancer and infectious disease
SG11201609118RA (en) 2014-05-15 2016-11-29 Univ Singapore Modified natural killer cells and uses thereof
CN104611293B (zh) * 2014-12-30 2017-10-13 杭州特马赛生物技术有限公司 一种体外中药组合诱导扩增nk细胞的方法及其应用
CN104789527B (zh) * 2015-05-15 2018-05-29 江苏杰晟生物科技有限公司 一种自体自然杀伤细胞鸡尾酒式培养的制备方法及其试剂盒产品
CN107064085B (zh) * 2017-03-16 2021-05-11 中国人民解放军三〇七医院 自然杀伤细胞活性测定方法
CN110494557A (zh) 2017-03-27 2019-11-22 新加坡国立大学 用于离体扩增和活化自然杀伤细胞的刺激细胞系
SG11201908492PA (en) 2017-03-27 2019-10-30 Nat Univ Singapore Truncated nkg2d chimeric receptors and uses thereof in natural killer cell immunotherapy
US12258381B2 (en) 2018-02-09 2025-03-25 National University Of Singapore Activating chimeric receptors and uses thereof in natural killer cell immunotherapy
CN118546960A (zh) 2019-03-05 2024-08-27 恩卡尔塔公司 Cd19定向性嵌合抗原受体及其在免疫疗法中的用途
CN112251405A (zh) * 2020-10-15 2021-01-22 大连天星生物技术有限责任公司 一种体外高效诱导扩增nk细胞的方法
CN112285083B (zh) * 2020-10-28 2022-01-07 上海睿钰生物科技有限公司 一种细胞杀伤效力的评价方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5415874A (en) * 1989-10-31 1995-05-16 The Board Of Trustees Of The Leland Stanford Junior University Natural killer cell lines and clones with antigen specificity
WO1997039108A1 (de) * 1996-04-17 1997-10-23 Boehringer Mannheim Gmbh Verfahren zur herstellung und vermehrung von lymphozyten
FR2775692B1 (fr) * 1998-03-03 2000-06-16 Roussy Inst Gustave Methodes d'activation de cellules tueuses naturelles (nk) et moyens de mise en oeuvre

Also Published As

Publication number Publication date
CN1399675A (zh) 2003-02-26
JP2001149069A (ja) 2001-06-05
ATE348876T1 (de) 2007-01-15
TWI224137B (en) 2004-11-21
CA2393322A1 (en) 2001-05-31
EP1233058A1 (en) 2002-08-21
JP3619853B2 (ja) 2005-02-16
EP1233058B1 (en) 2006-12-20
WO2001038494A1 (en) 2001-05-31
EP1233058A4 (en) 2003-01-15
DE60032508D1 (de) 2007-02-01
KR20030032905A (ko) 2003-04-26
CN1237170C (zh) 2006-01-18

Similar Documents

Publication Publication Date Title
HK1048498A1 (zh) 自然殺傷細胞的增殖方法
DK1082410T3 (da) Humane CD45 - og/eller fibroblast mesenchymale stamceller
ES2571355T3 (es) Sistema de cultivo sin células alimentadoras ni xenocontaminantes para células madre embrionarias humanas
DK1226233T3 (da) Multipotente voksne stamceller og fremgangsmåder til isolering heraf
BR0009562A (pt) arpe- 19 como uma linhagem de célula de plataforma para liberação com base em célula encapsulada
EP2410044A3 (en) Stem cells culture systems
AU2369595A (en) In vitro growth of functional islets of langerhans and in vivo uses thereof
PT794790E (pt) Libertacao localizada de factores que aumentam a sobrevivencia de celulas transplantadas
AU2003269820A8 (en) Miniature biological fuel cell that is operational under physiological conditions, and associated devices and methods
WO2002072762A3 (en) Use of rna interference for the creation of lineage specific es and other undifferentiated cells and production of differentiated cells in vitro by co-culture
DE69837393D1 (de) Stimulierung von hämatopoietischen zellen im vitro
ATE286118T1 (de) Anwendungen für humane nicht autologe, mesenchymale stammzellen
DK1210411T3 (da) Sammensætninger og fremgangsmåder til forbedret celledyrkning
BR0312764A (pt) Cardiomiócitos funcionais originados de células-tronco embrionárias humanas
DE69329779D1 (de) Verfahren zur behandlung geschädigter und verminderter zellen
FR2662698B1 (zh)
AR022583A1 (es) Secuencias antitumorales anti-sentido dirigidas contra los componentes r1 y r2 de la reductasa de los ribonucleotidos
WO2002010350A1 (en) Method of proliferating natural killer cells
ATE335808T1 (de) Herstellung von zellsuspensionen
ATE314461T1 (de) Vermehrte und genetisch modifizierte populationen menschlicher hämatopoitischer stammzellen
RU2008104232A (ru) Способ генерации антиген-специфических противотуберкулезных клеток
MXPA03009312A (es) Metodo para trasplante autologo.
BR9916726A (pt) HormÈnio do crescimento humano para estimular a mobilização de células tronco hematopoiéticas pluripotentes
AU8478601A (en) Methods for culturing human lung mast cells and uses thereof
AU2148201A (en) Particulate construct for use in the transplantation field